Aerospace startup Boom says they've proven quiet supersonic flight is possible with their passenger airplanes after a ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...

A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca ...

We recently published a list of 10 Safest Dividend Stocks in the UK. In this article, we are going to take a look at where ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

Today, Benzinga's options scanner spotted 9 options trades for AstraZeneca. This isn't normal. The overall sentiment of these ...

Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company's standalone net profit surged to Rs 54.68 crore in Q3 FY25 as compared with Rs 15.80 crore in Q3 FY24.

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...